MedTrace Logo

Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study

NCT05223218 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-07-03

No results posted yet for this study

Summary

This Pilot Study is to investigate the tear proteins in a multitude of cancer types and indulge in biomarker discovery to manufacture simple, accurate, and novel tear-based diagnostic tests.

Conditions

Interventions

OTHER

Schirmer strip, a Class I Medical Device typically used to test for dry eye.

Schirmer strip is a Class I Medical Device typically used to test for dry eye and will be used to collect lacrimal tear fluids.

Sponsors & Collaborators

  • Arkansas Urology

    collaborator UNKNOWN

  • CARTI

    collaborator UNKNOWN

  • Namida Lab

    lead INDUSTRY

Principal Investigators

  • Prashanth Ravishankar, PhD · Namida Lab Inc

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-25
Primary Completion
2023-11-30
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05223218 on ClinicalTrials.gov